Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Randall

Showing results (381-390 of 410) with videos related to

Pageof 41
Sort By:
Frontiers in Oncology|January 28, 2021
Multiphasic Prehabilitation Across the Cancer Continuum: A Narrative Review and Conceptual FrameworkDaniel Santa Mina, Stefanus J van Rooijen, Enrico M Minnella, et al.
Gynecologic Oncology|June 14, 2023
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)B Pothuri, S V Blank, T K Myers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinomaM H Voss, A Hussain, N Vogelzang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 23, 2025
The GOG Foundation and EVA/LACOG partnership: a collaborative strategic alliance for clinical trial executionFernando Maluf, Robert L Coleman, Angélica Nogueira-Rodrigues, et al.
Scientific Reports|April 1, 2021
Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and TogoSarah Gwyn, Marcel S Awoussi, Ana Bakhtiari, et al.
Scientific Reports|September 2, 2021
Publisher Correction: Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and TogoSarah Gwyn, Marcel S Awoussi, Ana Bakhtiari, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 2, 2021
Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non-demented adultsGilda E Ennis, Rebecca L Koscik, Yue Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2022
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation StudyBenoit You, Christopher Purdy, Larry J Copeland, et al.
JMIR Human Factors|September 8, 2025
Personalized Interactive Music Systems for Physical Activity and Exercise: Exploratory Systematic Review and Meta-AnalysisAndrew Danso, Tiia Kekäläinen, Friederike Koehler, et al.
Gynecologic Oncology|August 28, 2021
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancerDavid M O'Malley, Ana Oaknin, Bradley J Monk, et al.
Pageof 41

Showing results (381-390 of 410) with videos related to

Sort By:
Pageof 41
Frontiers in Oncology|January 28, 2021
Multiphasic Prehabilitation Across the Cancer Continuum: A Narrative Review and Conceptual FrameworkDaniel Santa Mina, Stefanus J van Rooijen, Enrico M Minnella, et al.
Gynecologic Oncology|June 14, 2023
Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)B Pothuri, S V Blank, T K Myers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinomaM H Voss, A Hussain, N Vogelzang, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 23, 2025
The GOG Foundation and EVA/LACOG partnership: a collaborative strategic alliance for clinical trial executionFernando Maluf, Robert L Coleman, Angélica Nogueira-Rodrigues, et al.
Scientific Reports|April 1, 2021
Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and TogoSarah Gwyn, Marcel S Awoussi, Ana Bakhtiari, et al.
Scientific Reports|September 2, 2021
Publisher Correction: Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and TogoSarah Gwyn, Marcel S Awoussi, Ana Bakhtiari, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 2, 2021
Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non-demented adultsGilda E Ennis, Rebecca L Koscik, Yue Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2022
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation StudyBenoit You, Christopher Purdy, Larry J Copeland, et al.
JMIR Human Factors|September 8, 2025
Personalized Interactive Music Systems for Physical Activity and Exercise: Exploratory Systematic Review and Meta-AnalysisAndrew Danso, Tiia Kekäläinen, Friederike Koehler, et al.
Gynecologic Oncology|August 28, 2021
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancerDavid M O'Malley, Ana Oaknin, Bradley J Monk, et al.
Pageof 41